20 episodes

"HIV News & Views" is an ongoing podcast series from TheBody.com/TheBodyPRO.com in which we talk with HIV doctors, researchers, advocates and others, to get their takes on important HIV news.

HIV News & Views TheBody.com

    • Science

"HIV News & Views" is an ongoing podcast series from TheBody.com/TheBodyPRO.com in which we talk with HIV doctors, researchers, advocates and others, to get their takes on important HIV news.

    Innovative Widget Provides N.Y. Emergency Rooms With PEP Info

    Innovative Widget Provides N.Y. Emergency Rooms With PEP Info

    In New York, a new resource may help put an end to the confusion among emergency and general health care providers regarding HIV post-exposure prophylaxis (PEP) administration. The resource is a recently developed "widget" -- an easy-to-use, computer-based tool -- that advises health professionals on best practices for giving PEP. In this interview, Antonio Urbina, M.D., of St. Vincent's Medical Center describes the widget's functions while detailing the fine points of PEP.

    • 19 min
    Earlier HIV/AIDS Treatment Recommended in New Guidelines: Expert Summarizes

    Earlier HIV/AIDS Treatment Recommended in New Guidelines: Expert Summarizes

    Looking for an expert summary of the latest revisions to the official U.S. HIV treatment guidelines? Check out this exclusive interview with David Wohl, M.D., a prominent HIV physician/researcher and a member of the expert panel responsible for revising the guidelines. In this concise summary with TheBody.com's editorial director, Dr. Wohl walks us through the updated guidelines and explains the importance of the new revisions.

    • 22 min
    Overweight People With HIV See Lower CD4 Gain While on HIV Medications, Study Suggests

    Overweight People With HIV See Lower CD4 Gain While on HIV Medications, Study Suggests

    Until the mid-1990s in the U.S., packing on a few extra pounds seemed like a good thing: It helped protect a person against the dangers of wasting and HIV's destructive effects on the immune system. But today, for people on potent HIV treatment, those extra pounds may no longer help -- in fact, they may reduce the immune benefits of HIV meds, a new study suggests.

    • 24 min
    HIV/AIDS Activists Give Harsh Grades to Drug Companies

    HIV/AIDS Activists Give Harsh Grades to Drug Companies

    Abbott Laboratories: F. Hoffman-La Roche Ltd.: D. Boehringer Ingelheim: D+. If the nine major HIV drug companies were in school, most would probably be in detention, according to a new "report card" issued by the AIDS Treatment Activists Coalition (ATAC). ATAC graded the drug companies in five different categories, including fair pricing and their relationship with the HIV community. Some did alright -- Merck & Co. and Tibotec Therapeutics both got B's -- but most didn't fare as well. In this one-on-one interview, we get the nitty-gritty on this telling report from longtime HIV/AIDS journalist and activist Bob Huff, a member of ATAC's board of directors.

    • 36 min
    HIV and Swine Flu (H1N1): An Update on Intersecting Pandemics

    HIV and Swine Flu (H1N1): An Update on Intersecting Pandemics

    We had a short break from the panic over swine flu (H1N1). But as this year's flu season approaches in the U.S. and the rest of the Northern Hemisphere, fear appears to be ramping up again. Even many experts are wondering just how bad this winter will be. Have we learned anything new about swine flu since the global outbreak began in April, about what lies in store over the months to come, and about what people with HIV can do to protect themselves? We caught up with top HIV physician Joel Gallant, M.D., M.P.H., for the latest news and predictions.

    • 13 min
    What Does H1N1 (Swine) Flu Mean for People With HIV/AIDS?

    What Does H1N1 (Swine) Flu Mean for People With HIV/AIDS?

    As a swine flu virus appears to make its way across the world, so has misinformation and confusion about what the virus is and what sort of threat it poses, particularly for people with weakened immune systems or some people living with HIV. To help us fill in that knowledge gap, we've asked Dr. Joel Gallant for some insights. Dr. Gallant is a professor of medicine and epidemiology in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine and he happens to be one of the leading HIV specialists in the United States.

    • 11 min

Top Podcasts In Science